Decades of research show the mercury-containing preservative thimerosal is safe in vaccines, but CDC's new advisory panel is ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

“In our results, a substantial proportion of infections was prevented when transmissibility was similar to that encountered in typical influenza seasons, vaccine effectiveness was within the ranges ...

The vaccine will offer protection against H5N1 and is projected to be effective against future viral mutations.

During monsoons, influenza is among the most prevalent viral infections, spreading quickly among kids. So, vaccination before rains set in is crucial. Here's why.

New analysis warns that suboptimal clinical trial designs and overreliance on surrogate markers may allow less effective flu ...

In just 3 years, the Influenza Vaccines Research and Development (R&D) Roadmap Initiative has demonstrated important ...

RSV has outstripped severe Covid and flu hospitalisation rates and proved itself more fatal than either of the flu season ...

Influenza significantly impacted adults aged 50 to 64 years and younger adults with chronic conditions, but risk can be reduced with RIV.

The federal government should approve a vaccine against highly pathogenic avian influenza (HPAI) in dairy cattle, the ...

H5N1 avian influenza has long been a concerning virus. Since its discovery in 1996 in waterfowl, bird flu has occasionally ...

Osivax has released phase 2a trial data confirming that its broad-spectrum flu vaccine candidate, OVX836, can be safely ...